These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 2775212)

  • 1. Changes in collagen stability and folding in lethal perinatal osteogenesis imperfecta. The effect of alpha 1 (I)-chain glycine-to-arginine substitutions.
    Baker AT; Ramshaw JA; Chan D; Cole WG; Bateman JF
    Biochem J; 1989 Jul; 261(1):253-7. PubMed ID: 2775212
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lethal perinatal osteogenesis imperfecta due to the substitution of arginine for glycine at residue 391 of the alpha 1(I) chain of type I collagen.
    Bateman JF; Chan D; Walker ID; Rogers JG; Cole WG
    J Biol Chem; 1987 May; 262(15):7021-7. PubMed ID: 3108247
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Substitution of arginine for glycine 664 in the collagen alpha 1(I) chain in lethal perinatal osteogenesis imperfecta. Demonstration of the peptide defect by in vitro expression of the mutant cDNA.
    Bateman JF; Lamande SR; Dahl HH; Chan D; Cole WG
    J Biol Chem; 1988 Aug; 263(24):11627-30. PubMed ID: 3403550
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Substitution of serine for alpha 1(I)-glycine 844 in a severe variant of osteogenesis imperfecta minimally destabilizes the triple helix of type I procollagen. The effects of glycine substitutions on thermal stability are either position of amino acid specific.
    Pack M; Constantinou CD; Kalia K; Nielsen KB; Prockop DJ
    J Biol Chem; 1989 Nov; 264(33):19694-9. PubMed ID: 2511192
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lethal perinatal osteogenesis imperfecta due to a type I collagen alpha 2(I) Gly to Arg substitution detected by chemical cleavage of an mRNA:cDNA sequence mismatch.
    Bateman JF; Moeller I; Hannagan M; Chan D; Cole WG
    Hum Mutat; 1992; 1(1):55-62. PubMed ID: 1284475
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Substitutions of aspartic acid for glycine-220 and of arginine for glycine-664 in the triple helix of the pro alpha 1(I) chain of type I procollagen produce lethal osteogenesis imperfecta and disrupt the ability of collagen fibrils to incorporate crystalline hydroxyapatite.
    Culbert AA; Lowe MP; Atkinson M; Byers PH; Wallis GA; Kadler KE
    Biochem J; 1995 Nov; 311 ( Pt 3)(Pt 3):815-20. PubMed ID: 7487936
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of three osteogenesis imperfecta collagen alpha 1(I) glycine to serine mutations demonstrating a position-dependent gradient of phenotypic severity.
    Bateman JF; Moeller I; Hannagan M; Chan D; Cole WG
    Biochem J; 1992 Nov; 288 ( Pt 1)(Pt 1):131-5. PubMed ID: 1445258
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Substitutions for arginine at position 780 in triple helical domain of the α1(I) chain alter folding of the type I procollagen molecule and cause osteogenesis imperfecta.
    Makareeva E; Sun G; Mirigian LS; Mertz EL; Vera JC; Espinoza NA; Yang K; Chen D; Klein TE; Byers PH; Leikin S
    PLoS One; 2018; 13(7):e0200264. PubMed ID: 29990383
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Substitutions for glycine alpha 1-637 and glycine alpha 2-694 of type I procollagen in lethal osteogenesis imperfecta. The conformational strain on the triple helix introduced by a glycine substitution can be transmitted along the helix.
    Tsuneyoshi T; Westerhausen A; Constantinou CD; Prockop DJ
    J Biol Chem; 1991 Aug; 266(24):15608-13. PubMed ID: 1874719
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Substitution of arginine for glycine at position 847 in the triple-helical domain of the alpha 1 (I) chain of type I collagen produces lethal osteogenesis imperfecta. Molecules that contain one or two abnormal chains differ in stability and secretion.
    Wallis GA; Starman BJ; Schwartz MF; Byers PH
    J Biol Chem; 1990 Oct; 265(30):18628-33. PubMed ID: 2211725
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Amino acid sequence environment modulates the disruption by osteogenesis imperfecta glycine substitutions in collagen-like peptides.
    Yang W; Battineni ML; Brodsky B
    Biochemistry; 1997 Jun; 36(23):6930-5. PubMed ID: 9188687
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Substitution of cysteine for glycine-alpha 1-691 in the pro alpha 1(I) chain of type I procollagen in a proband with lethal osteogenesis imperfecta destabilizes the triple helix at a site C-terminal to the substitution.
    Steinmann B; Westerhausen A; Constantinou CD; Superti-Furga A; Prockop DJ
    Biochem J; 1991 Nov; 279 ( Pt 3)(Pt 3):747-52. PubMed ID: 1953667
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mutations that substitute serine for glycine alpha 1-598 and glycine alpha 1-631 in type I procollagen. The effects on thermal unfolding of the triple helix are position-specific and demonstrate that the protein unfolds through a series of cooperative blocks.
    Westerhausen A; Kishi J; Prockop DJ
    J Biol Chem; 1990 Aug; 265(23):13995-4000. PubMed ID: 2116413
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effects of different cysteine for glycine substitutions within alpha 2(I) chains. Evidence of distinct structural domains within the type I collagen triple helix.
    Wenstrup RJ; Shrago-Howe AW; Lever LW; Phillips CL; Byers PH; Cohn DH
    J Biol Chem; 1991 Feb; 266(4):2590-4. PubMed ID: 1990009
    [TBL] [Abstract][Full Text] [Related]  

  • 15. G76E substitution in type I collagen is the first nonlethal glutamic acid substitution in the alpha1(I) chain and alters folding of the N-terminal end of the helix.
    Cabral WA; Chernoff EJ; Marini JC
    Mol Genet Metab; 2001 Apr; 72(4):326-35. PubMed ID: 11286507
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of a type I collagen alpha 2(I) glycine-586 to valine substitution in osteogenesis imperfecta type IV. Detection of the mutation and prenatal diagnosis by a chemical cleavage method.
    Bateman JF; Hannagan M; Chan D; Cole WG
    Biochem J; 1991 Jun; 276 ( Pt 3)(Pt 3):765-70. PubMed ID: 2064612
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A structural mutation of the collagen alpha 1(I)CB7 peptide in lethal perinatal osteogenesis imperfecta.
    Bateman JF; Mascara T; Chan D; Cole WG
    J Biol Chem; 1987 Apr; 262(10):4445-51. PubMed ID: 3558348
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structural study of a mutant type I collagen from a patient with lethal osteogenesis imperfecta containing an intramolecular disulfide bond in the triple-helical domain.
    Traub W; Steinmann B
    FEBS Lett; 1986 Mar; 198(2):213-6. PubMed ID: 3956729
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thermal stability and folding of the collagen triple helix and the effects of mutations in osteogenesis imperfecta on the triple helix of type I collagen.
    Bächinger HP; Morris NP; Davis JM
    Am J Med Genet; 1993 Jan; 45(2):152-62. PubMed ID: 8456797
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Severity of osteogenesis imperfecta and structure of a collagen-like peptide modeling a lethal mutation site.
    Radmer RJ; Klein TE
    Biochemistry; 2004 May; 43(18):5314-23. PubMed ID: 15122897
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.